Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Maintains Outperform on Abbott Laboratories, Raises Price Target to $130

Credit Suisse analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $120 to $130.
byBenzinga Newsdesk
July 23, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Credit Suisse analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $120 to $130.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts